Stock Research: Teleflex

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Teleflex

NYSE:TFX US8793691069
61
  • Value
    88
  • Growth
    9
  • Safety
    Safety
    100
  • Combined
    93
  • Sentiment
    22
  • 360° View
    360° View
    61
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Teleflex Incorporated is a global provider of medical technologies. It operates in the medical technology industry, offering solutions in anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It operates in the Americas, EMEA, and Asia Pacific regions. In the last fiscal year, the company had a market cap of $5,014 million, profits of $1,703 million, and revenue of $3,047 million, with 14,100 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 61 (better than 61% compared with alternatives), overall professional sentiment and financial characteristics for the stock Teleflex are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Teleflex. The consolidated Value Rank has an attractive rank of 100, which means that the share price of Teleflex is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 100% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 88. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 22. Professional investors are more confident in 78% other stocks. The consolidated Growth Rank also has a low rank of 9, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 91 of its competitors have better growth. ...read more

more
Index
Dividends USA
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 100 94 95
Growth
9 13 31 19
Safety
Safety
88 84 86 34
Sentiment
22 55 43 20
360° View
360° View
61 86 100 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 24 20 17
Opinions Change
50 50 44 22
Pro Holdings
n/a 57 84 94
Market Pulse
27 81 43 17
Sentiment
22 55 43 20
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 100 94 95
Growth
9 13 31 19
Safety Safety
88 84 86 34
Combined
93 92 98 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
96 96 82 70
Price vs. Earnings (P/E)
67 60 42 56
Price vs. Book (P/B)
80 72 69 63
Dividend Yield
93 82 80 86
Value
100 100 94 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
63 26 21 19
Profit Growth
23 27 37 60
Capital Growth
21 55 45 23
Stock Returns
13 17 65 45
Growth
9 13 31 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
60 56 44 29
Refinancing
57 45 43 23
Liquidity
72 76 85 78
Safety Safety
88 84 86 34

Similar Stocks

Discover high‑ranked alternatives to Teleflex and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.